Digoxin bioavailability: evaluation of a generic tablet and proposed FDA guidelines.
D001682:Biological Availability; D004077:Digoxin / Q000008:administration & dosage / Q000378:metabolism* / Q000592:standards; D006801:Humans; D008297:Male; D013607:Tablets; D014481:United States; D014486:United States Food and Drug Administration
D013607:Tablets; D004077:Digoxin